WallStreetZenWallStreetZen

NASDAQ: NERV
Minerva Neurosciences Inc Stock

$2.48-0.04 (-1.59%)
Updated May 20, 2024
NERV Price
$2.48
Fair Value Price
N/A
Market Cap
$17.34M
52 Week Low
$2.29
52 Week High
$13.49
P/E
-0.55x
P/B
-0.47x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$31.60M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-2.38
Operating Cash Flow
-$21M
Beta
0.86
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

NERV Overview

Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone for the treatment of schizophrenia; and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein for the treatment of Parkinson's disease and other neurodegenerative disorders. Minerva Neurosciences, Inc. has a license agreement with Mitsubishi Tanabe Pharma Corporation to develop, sell, and import roluperidone globally excluding Asia. The company was formerly known as Cyrenaic Pharmaceuticals, Inc. and changed its name to Minerva Neurosciences, Inc. in 2013. Minerva Neurosciences, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts.

Zen Score

Industry Average (22)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how NERV scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

NERV is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
NERV is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
NERV's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more NERV due diligence checks available for Premium users.

Be the first to know about important NERV news, forecast changes, insider trades & much more!

NERV News

Valuation

NERV fair value

Fair Value of NERV stock based on Discounted Cash Flow (DCF)
Price
$2.48
Fair Value
$11.92
Undervalued by
79.19%
NERV is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

NERV price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.55x
Industry
8.16x
Market
31.12x

NERV price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
-0.47x
Industry
6.06x

NERV's financial health

Profit margin

Revenue
$0.0
Net Income
-$8.6M
Profit Margin
0%
NERV's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$50.5M
Liabilities
$87.1M
Debt to equity
-2.38
NERV's short-term assets ($35.62M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
NERV's long-term liabilities ($84.27M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
NERV's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
NERV's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$6.1M
Investing
$0.0
Financing
$0.0
NERV's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

NERV vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
NERV$17.34M-1.59%-0.55x-0.47x
GLTO$17.24M+2.42%-0.56x0.61x
SNTI$17.16M-1.83%-0.26x0.31x
TCRT$17.77M-4.31%-0.60x3.71x
PMCB$18.11M+1.90%-1.78x0.58x

Minerva Neurosciences Stock FAQ

What is Minerva Neurosciences's quote symbol?

(NASDAQ: NERV) Minerva Neurosciences trades on the NASDAQ under the ticker symbol NERV. Minerva Neurosciences stock quotes can also be displayed as NASDAQ: NERV.

If you're new to stock investing, here's how to buy Minerva Neurosciences stock.

What is the 52 week high and low for Minerva Neurosciences (NASDAQ: NERV)?

(NASDAQ: NERV) Minerva Neurosciences's 52-week high was $13.49, and its 52-week low was $2.29. It is currently -81.62% from its 52-week high and 8.49% from its 52-week low.

How much is Minerva Neurosciences stock worth today?

(NASDAQ: NERV) Minerva Neurosciences currently has 6,993,406 outstanding shares. With Minerva Neurosciences stock trading at $2.48 per share, the total value of Minerva Neurosciences stock (market capitalization) is $17.34M.

Minerva Neurosciences stock was originally listed at a price of $48.40 in Jul 1, 2014. If you had invested in Minerva Neurosciences stock at $48.40, your return over the last 9 years would have been -94.88%, for an annualized return of -28.12% (not including any dividends or dividend reinvestments).

How much is Minerva Neurosciences's stock price per share?

(NASDAQ: NERV) Minerva Neurosciences stock price per share is $2.48 today (as of May 20, 2024).

What is Minerva Neurosciences's Market Cap?

(NASDAQ: NERV) Minerva Neurosciences's market cap is $17.34M, as of May 21, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Minerva Neurosciences's market cap is calculated by multiplying NERV's current stock price of $2.48 by NERV's total outstanding shares of 6,993,406.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.